Meta-analysis: Its strengths and limitations

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 6, 2008, Pages 431-439

  Walker, Esteban ^a   Hernandez, Adrian V ^a   Kattan, Michael W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45849098367     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.6.431     Document Type: Review

References (30)

1. Berlin JA, Colditz GA. The role of meta-analysis in the regulatory process for food, drugs, and devices. JAMA 1999; 281:830-834.
2. Ballar JC. The promise and problems of meta-analysis. N Engl J Med 1997; 337:559-561.
3. Simon R. Meta-analysis of clinical trials: opportunities and limitations. In: Stangl DK, Berry DA, editors. Meta-Analysis in Medicine and Health Policy. New York: Marcel Dekker, 2000.
4. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356:2457-2471.
5. Turner EH, Matthews AM, Linardatos E. et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358:252-260.
6. LeLorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997, 337:536-542.
7. Steinbrook R. Searching for the right search - reaching the medical literature. Engl J Med 2006; 354:4-7.
8. Dickersin K, Scherer R, Lefebvre C. Systematic reviews: identifying relevant studies for systematic reviews. BMJ 1994; 309:1286-1291.
9. De Luca G, Suryapranta H, Stone GW, et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 2007; doi:10.1016/j.ijcard.2007.03.112.
10. Ng TT, McGory MJ, Ko CY, et al. Meta-analysis in surgery. Arch Surg 2006; 141:1125-1130.
11. Ray CE, Prochazka A. The need for anticoagulation following inferior vena cava filter placement: systematic review. Cardiovasc Intervent Radiol 2007; 31:316-324.
12. Nicolucci A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A. Quality evolution and clinical implications of randomized controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA 1989; 262:2101-2107.
13. Marsoni S, Torri V, Taiana A. Critical review of the quality and development of randomized clinical trials and their influence on the treatment of advanced epithelial ovarian cancer. Ann Oncol 1990; 1:343-350.
14. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
15. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007, 49:403-414.
16. Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003; 22:2113-2126.
17. Dentali F, Doukelis D, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146:278-288.
18. Whitehead A. Meta-Analysis of Controlled Clinical Trials. New York: Wiley, 2002.
19. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncology 2007; 8:226-234.
20. Trivella M, Pezzella F, Pastorino U, et al. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncology 2007; 8:488-499.
21. Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials (Cochrane Methodology Review). In: The Cochrane Library, Issue 1, 2003. Oxford-update Software.
22. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000; 284:72-78.
23. Chan WS, Ray J, Wai EK, et al. Risk of stroke in women exposed to low-dose oral contraceptives. Arch Intern Med 2004; 164:741-747.
24. Gillum LA, Johnston SC. Oral contraceptives and stroke risk: the debate continues. Lancet 2004; 3:453-454.
25. Bhutta AT, Cleves MA, Casey PH, et al. Cognitive and behavioral outcomes of school-aged children who were born preterm. JAMA 2002; 288:728-737.
26. De Luca G, Suryapranta H, Stone GW, et al. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 2007; 153:343-353.
27. Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine - reporting of subgroup analyses in clinical trials. N Engl J Med 2007; 357:2189-2194.
28. Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare events: the rosiglitazone link with myocardial infarction and cardiac death. Stat Med 2007; 26:4375-4385.
29. Bracken MB. Rosiglitazone and cardiovascular risk. N Engl J Med 2007, 357:937-938.
30. Sutton AJ, Lambert PC, Hellmich M, et al. Meta-analysis in practice: a critical review of available software. In: Stangl DK, Berry DA, editors. Meta-Analysis in Medicine and Health Policy. New York: Marcel Dekker, 2000.